Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/2CUREX stock hub

STO/2CUREX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/2CUREXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

44.4M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/2CUREXSTO/2CUREX

—

Loading chart…

In the news

Latest news · STO/2CUREX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-174.8

P25 n/aP50 n/aP75 n/a

ROIC-119.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/2CUREX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

SEK

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	14
Employees Change	0%
Employees Change Percent	0
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0010468124
Last refreshed	2026-05-10
Market cap	SEK 44.4M
Price	SEK 1.77
Price currency	SEK
Rev Per Employee	141,142.86x
Sector	Healthcare
Sic	3845
Symbol	sto/2CUREX
Website	https://www.2curex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-59.36%
FCF yield	-50.94%
P/B ratio	15.94x
P/S ratio	22.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	SEK -7.6M
Net Income	SEK -26.3M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	-1,567.71%
Profit Per Employee	SEK -1.9M
ROA	-97.99
Roa5y	-29.94
ROCE	-1,036.2
ROE	-174.8
Roe5y	-50.41
ROIC	-119.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.06%
Cagr3y	-36.82%
Cagr5y	-40.34%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth	-49.75x
Revenue Growth Q	-63.07x
Revenue Growth Quarters	5x
Revenue Growth Years	0x
Revenue Growth3 Y	-47.56x
Revenue Growth5 Y	-29.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.11
Assets	SEK 7M
Cash	SEK 3.1M
Current Assets	SEK 6.4M
Current Liabilities	SEK 4.3M
Equity	SEK 2.8M
Interest Coverage	-9.77
Liabilities	SEK 4.3M
Long Term Assets	SEK 608,000
Long Term Liabilities	SEK 0
Net Cash	SEK 3.1M
Net Cash By Market Cap	SEK 7.05
Net Cash Growth	-88.1%
Net Debt Equity	SEK -1.12
Tangible Book Value	SEK 2.8M
Tangible Book Value Per Share	SEK 0.16
WACC	20.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.51
Net Working Capital	SEK -952,000
Quick ratio	1.51
Working Capital	SEK 2.2M
Working Capital Turnover	SEK 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	SEK 0.08
Dividend Years	1
Dividend Yield	4.75%
Ex Div Date	2025-06-27
Last Dividend	SEK 0.08

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.05%
200-day SMA	1.66
3Y total return	-74.79%
50-day SMA	1.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.44%
All Time High	31.5
All Time High Change	-94.39%
All Time High Date	2021-03-01
All Time Low	0.2
All Time Low Change	770.94%
All Time Low Date	2024-05-07
ATR	0.21
Beta	3.03
Beta1y	2
Beta2y	2.05
Ch YTD	244
High	1.86
High52	5.52
High52 Date	2025-06-10
High52ch	-67.97%
Low	1.61
Low52	0.51
Low52 Date	2025-12-30
Low52ch	243.97%
Ma50ch	24.86%
Price vs 200-day SMA	6.76%
RSI	56.3
RSI Monthly	47.48
RSI Weekly	52.87
Sharpe ratio	0.98x
Sortino ratio	2.44
Total Return	4.75%
Tr YTD	244
Tr1m	67.11%
Tr1w	-6.06%
Tr3m	-9.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -28.9M
Operating margin	-1,460.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	25,102,916
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -23.2M
Average Volume	170,320.3x
Bv Per Share	0.16
CAPEX	SEK -17,000
Ch1m	67.11
Ch1w	-6.06
Ch1y	9.14
Ch3m	-9.33
Ch3y	-75.44
Ch5y	-92.63
Ch6m	66.79
Change	8.33%
Change From Open	9.81
Close	1.63
Days Gap	-1.35
Depreciation Amortization	241,000
Dollar Volume	324,435.1
Earnings Date	2026-05-21
EBIT	SEK -28.9M
EBITDA	SEK -28.6M
EPS	SEK -1.5
F Score	2
FCF	SEK -22.6M
FCF Per Share	SEK -0.9
Fiscal Year End	December
Founded	2,006
Income Tax	SEK -4.6M
Investing CF	-6,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2024-06-30
Ma150	1.38
Ma150ch	27.84%
Ma20	1.6
Ma20ch	10.64%
Net CF	-23,163,000
Next Earnings Date	2026-05-21
Open	1.61
Payment Date	2025-07-03
Position In Range	62.2
Ppne	608,000
Price Date	2026-05-08
Ptbv Ratio	15.94
Relative Volume	1.13x
Revenue	1,976,000x
SBC By Revenue	27.48x
Share Based Comp	543,000
Tax By Revenue	-234.41x
Tr6m	66.79%
Volume	183,504
Z Score	-9.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

STO/2CUREX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.8%

$0.08 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2025-06-27

Performance

STO/2CUREX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

STO/2CUREX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

+6.8%

50/200-day relationship not available

Beta (5Y)

3.03

More volatile than the market

Sharpe ratio

0.98

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/2CUREX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/2CUREX stock rating?

sto/2CUREX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/2CUREX analysis?

The full report lives at /stocks/sto/2CUREX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/2CUREX?

The latest report frames sto/2CUREX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/2CUREX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.